当前位置:
X-MOL 学术
›
BJOG An Int. J. Obstet. Gynaecol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The Use of Novel Therapies in the Management of Haemolytic Disease of the Fetus and Newborn (HDFN)
BJOG: An International Journal of Obstetrics & Gynaecology ( IF 4.7 ) Pub Date : 2024-12-17 , DOI: 10.1111/1471-0528.18008 V. Cordell, A. Soe, T. Latham, V. L. Bills
BJOG: An International Journal of Obstetrics & Gynaecology ( IF 4.7 ) Pub Date : 2024-12-17 , DOI: 10.1111/1471-0528.18008 V. Cordell, A. Soe, T. Latham, V. L. Bills
Haemolytic disease of the fetus and newborn (HDFN) is a rare condition that causes a baby to develop anaemia while growing inside the woman; or after birth. Left untreated, this may lead to stillbirth or neonatal death.
中文翻译:
新疗法在胎儿和新生儿溶血性疾病 (HDFN) 管理中的应用
胎儿和新生儿溶血性疾病 (HDFN) 是一种罕见的疾病,会导致婴儿在女性体内生长时出现贫血;或出生后。如果不及时治疗,可能会导致死产或新生儿死亡。
更新日期:2024-12-18
中文翻译:
新疗法在胎儿和新生儿溶血性疾病 (HDFN) 管理中的应用
胎儿和新生儿溶血性疾病 (HDFN) 是一种罕见的疾病,会导致婴儿在女性体内生长时出现贫血;或出生后。如果不及时治疗,可能会导致死产或新生儿死亡。